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Background
When producing recombinant protein in E. coli for thera-
peutic use, it is desirable not only to obtain substantial
amounts of it, but also make sure that potential contami-
nants such as antibiotics or inducing agents (isopropyl-
beta-D-thiogalactopyranoside, IPTG or nalidixic acid) will
not taint the final product. To prevent this shortcoming
we can use expression systems where the promoter is acti-
vated by temperature shift, which denatures the control-
ling repressor protein cIts, allowing promoter activity.
While in our hands hGH was successfully expressed and
secreted in E. coli periplasm with yields in general well
above 1 μg/mL/A600, after a temperature shift from 30°C
to 42°C [1], attempts to express a related protein hor-
mone (hPRL) with basis on the same protocol were not
successful, providing 0.03 μg/mL/A600 at the most. Know-
ing that hPRL compared with hGH is a much more labile
protein, we tried to obtain it from the same strain, but
without the presence of the repressor protein and under
optimized temperature conditions.
Results
Human growth hormone periplasmic secretion in a bacte-
rial host that has also been transformed with the plasmid
pRK-248cIts, which contains the thermosensitive tran-
scription repressor (cIts) gene [2,3] has been studied at
different activation temperatures (Table 1). We can
observe that the λPL promoter is almost totally repressed
up to 37°C, while at 42°C its derepression permits a use-
ful hGH periplasmic secretion that is acceptable according
to previously established parameters [1]. In Table 1 we
also can see the results obtained in a set of different exper-
iments observing that without repressor still a quite high
hGH secretion (1 μg/mL/A600) is obtained at 30°C while
an apparently higher secretion is obtained at 42°C. Under
the same conditions, considering the described expression
vector into which the hGH gene has been substituted by
the hPRL gene, still with the presence of cIts, an approxi-
mately 130–180-fold lower secretion level for this hor-
mone is observed at 42°C. This led us to better study the
behaviour of our hPRL-producing E. coli strains, either
transformed or not with the plasmid pRK-248cIts. Con-
sidering not only that hPRL has been found a particularly
labile protein but also that the bacterial periplasmic envi-
roment can even be more detrimental to protein stability,
especially at high temperatures [4], it was decided to carry
out a study on hPRL periplasmic secretion by "activating"
at 30°, 35°, 37° and 42°C, with and without the presence
of the repressor. The "activating" temperature of 37°C,
and the bacterial strain lacking the cIts repressor, thus pro-
vided the highest hPRL secretion level, i.e. approximately
30-fold higher that those obtained with the equivalent
strain containing the repressor gene. In Table 2 we can
appreciate the statistical difference for prolactin yields
obtained under different temperatures. As already
observed for hGH (Table 1) the strain lacking the repres-
sor gene is producing a significantly higher (P < 0.001)
amount of hPRL, even at 42°C.
Since it has been reported that the lack of repressor could
easily lead to plasmid loss [3], a study was carried out
determining hPRL periplasmic yield in the strain lacking
from The 4th Recombinant Protein Production Meeting: a comparative view on host physiology
Barcelona, Spain. 21–23 September 2006
Published: 10 October 2006
Microbial Cell Factories 2006, 5(Suppl 1):P25 doi:10.1186/1475-2859-5-S1-P25
<supplement> <title> <p>The 4th Recombinant Protein Production Meeting: a comparative view on host physiology</p> </title> <sponsor> <note>The organisers would like to thank Novozymes Delta Ltd who generously supported the meeting.</note> </sponsor> <note>Meeting abstracts – A single PDF containing all abstracts in this supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1475-2859-5-S1-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1475-2859-5-S1-info.pdf</url> </supplement>
© 2006 Soares et al; licensee BioMed Central Ltd. Page 1 of 2
(page number not for citation purposes)
Microbial Cell Factories 2006, 5(Suppl 1):P25Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
cIts after two growth periods corresponding to 10 and 50
E. coli generations, obtaining 0.64 ± 0.05 and 0.78 ± 0.03
μg hPRL/mL/A600 respectively. Also the presence or not of
antibiotic (amp) did not influence the specific expression
yield for at least 40 generations.
This same strain is being utilized for setting up a rapid and
flexible feed batch fermentation in a laboratory bioreac-
tor, obtaining up to now ~7 μg hPRL/mL with an optical
density of 42.4 A600.
Conclusion
A relatively high hPRL periplasmic secretion (up to 0.9 μg/
mL/A600), never reported before, has been obtained by
constitutive expression of the unrepressed λPLpromoter,
at 37°C. The expression level is approximately 10-fold
higher than that obtained in previous work [5] by using
an IPTG-activated tac promoter. We can conclude that
these data open the way to the utilization of E. coli instead
of insect or mammalian expression systems for the pro-
duction of an authentic and highly homogeneous hPRL.
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Table 1: hGH periplasmic secretion level activating at different temperature and utilizing hGH-secreting W3110 strains, with or 
without the repressor gene (cIts).
temperature phGH-DsbA-λPL+ pRK-248 cIts (μg/mL/A600 ± SD) phGH-DsbA-λPL(μg/mL/A600 ± SD)
30°C 0.01 1.0 ± 0.14 (n = 2)
35°C 0.02 -
37°C 0,06 -
42°C 1,31 ± 0.38 (n = 4) 1.61 ± 0.11 (n = 3)
Table 2: hPRL periplasmic secretion level in E. coli W3110, at different temperatures utilizing a vector containing (phPRL-DsbA-cIts -
λPL) and one not containing (phPRL-DsbA-λPL) the repressor gene.
temperature phPRL-DsbA-λPL+ pRK-248 cIts (μg/mL/A600 ± SD) phPRL-DsbA-λPL(μg/mL/A600± SD) Statistical significance a
30°C 0.001 (n = 1) 0.14 ± 0.02 (n = 6) -
35°C - 0.73 ± 0.07 (n = 5) P < 0.001
37°C 0.03 (n = 1) 0.92 ± 0.10 (n = 6) P < 0.01
39°C - 0.60 ± 0.12 (n = 8) P < 0.001
42°C 0.02 (n = 1) 0.19 ± 0.05 (n = 4) P < 0.001
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